View Article

Abstract

Morinda citrifolia (Noni) is a medicinal plant widely used in traditional medicine for its antimicrobial properties. The present study aimed to evaluate the antimicrobial activity of Morinda citrifolia (Flowers) extract using nutrient broth medium, disc diffusion method, agar well diffusion method, and serial dilution techniques. Phytochemical screening was performed to identify active compounds, and molecular docking studies were carried out to analyze the interaction between phytoconstituents and microbial target proteins. The extract showed significant inhibition against selected microorganisms compared to blank control. Percentage inhibition was calculated using serial dilution results. Molecular docking revealed strong binding affinity of bioactive compounds with bacterial protein targets, supporting the experimental findings. The study confirms the antimicrobial potential of Morinda citrifolia and explains its mechanism at the molecular level.

Keywords

Morinda citrifolia, Antimicrobial activity, Disc diffusion method, Agar well diffusion method, Nutrient broth medium, Serial dilution, Molecular docking, Phytochemical analysis, Percentage inhibition.

Introduction

An antimicrobial is an agent that kills microorganisms (microbicide) or stops their growth (bacteriostatic agent). Antimicrobial medicines can be grouped according to the microorganisms they are used to treat.

For example, antibiotics are used against bacteria, and antifungals are used against fungi. They can also be classified according to their function.

Antimicrobial medicines to treat infection are known as antimicrobial chemotherapy, while antimicrobial drugs are used to prevent infection, which known as antimicrobial prophylaxis.

The main classes of antimicrobial agents are disinfectants (non-selective agents, such as bleach), which kill a wide range of microbes on surfaces to prevent the spread of illness, antiseptics which are applied to living tissue and help reduce infection during surgery, and antibiotics which destroy microorganisms within the body.

ANTIFUNGALS

Antifungals are used to kill or prevent further growth of fungi. In medicine, they are used as a treatment for infections such as athlete's foot, ringworm and thrush and work by exploiting differences between mammalian and fungal cells. Unlike bacteria, both fungi and humans are eukaryotes.

ANTIVIRAL

Antiviral drugs are a class of medication used specifically for treating viral infections. Like antibiotics, specific antivirals are used for specific viruses. They should be distinguished from vermicides, which actively deactivate virus particles outside the body.

ANTIPARASITIC:

Antiparasitic are a class of medications which are indicated for the treatment of parasitic diseases, such as those caused by helminthes, amoeba, ectoparasites, parasitic fungi, and protozoa, among others. Antiparasitic target the parasitic agents of the infections by destroying them or inhibiting their growth; they are usually effective against a limited number of parasites within a Particular class

MECHANISM OF ACTION OF ANTI MICROBIALS:

  1. Inhibition of Cell Wall Synthesis
  • Target: Peptidoglycan layer in bacterial cell walls
  • Effect: Weakens the cell wall, leading to cell lysis and death
  • Mainly active against: Gram-positive bacteria
    1. β-lactams: Penicillins, Cephalosporins, Glycopeptides: Vancomycin
  1. Disruption of Cell Membrane Function
  • Target: Cell membrane (phospholipid or sterol components)
  • Effect: Destroys membrane integrity → leakage of vital molecules → cell death
    1. Polymyxins (bacteria), Amphotericin B, Nystatin (fungi - target ergosterol)
  1. Inhibition of Protein Synthesis
  • Target: Bacterial ribosomes (30S or 50S subunits)
  • Effect: Blocks protein production → inhibits growth or kills cell
    1. Tetracyclines, Aminoglycosides (30S), Macrolides, Chloramphenicol (50S)
  1. Inhibition of Nucleic Acid Synthesis
  • Target: Enzymes for DNA or RNA replication
  • Effect: Prevents DNA replication or transcription → halts cell division
    1. Fluoroquinolones (inhibit DNA gyrase), Rifampin (inhibits RNA polymerase)

5. Inhibition of Essential Metabolic Pathways

  • Target: Enzymes in folic acid synthesis (used for DNA/RNA synthesis)
  • Effect: Starves the cell of critical nutrients
    1. Sulfonamide, Trimethoprim

PLANT PROFILE

NONI

Common name: Indian Mulberry, Great Morinda, Cheesefruit,

Scientific name: Morindia citrifolia

Family : Rubiaceae

Geographical  source: Kerala, Karnataka and Tamil Nadu

Scientific classification:

  • Kingdom : Plantae
  • Order : Gentianales
  • Family : Rubiaceae
  • Subfamily : Rubioideae
  • Genus : Morinda
  • Species : Morinda citrifolia

Vernacular names:

English : Indian Mulberry

Tamil : Nuna

Hindi : Bartundi

Telugu : Mogali

Kannada : Tagase maddi

Description:

Morinda citrifolia is a shrub or small tree up to 6 m tall, with grey-brown bark. The twigs are more or less square in cross-section and often fleshy. Stipules are present, very broad and obtuse at the apex, measuring up to 2 cm wide and long. The large glabrous leaves are elliptic to ovate in shape and have 6–9 pairs of lateral veins. The flowers are white and tubular with five lobes, measuring about 15 cm long and across.

The fruits are initially green, transitioning through pale yellow to white or grey, and when ripe they emit a pungent odour. They are irregularly ellipsoid or ovoid.

Chemical constituent:

Morinda citrifolia fruit powder contains carbohydrates and dietary fibre in moderate amounts. These macronutrients reside in the fruit pulp, as M. citrifolia juice has sparse nutrient content. Morinda citrifolia fruit contains diverse phytochemicals, including anthraquinones, lignans, oligo- and polysaccharides, flavonoids, iridoids, such as deacetylasperulosidic acid, scopoletin , fatty acids, catechin, beta-sitosterol, damnacanthal, and alkaloids.

Pharmacological profile:

  • Antibacterial
  • Antiviral
  • Antifungal
  • Anthelminthic
  • Antitumor
  • Analgesic
  • Hypotensive
  • Anti-inflammatory
  • Immune - enhancing effect.                  

MOLECULAR DESIGN:

Molecular design is the process of finding new medicines based on the knowledge of a biological target, it enabled the chemist to predict the structure and then it also allows the medicinal chemist to evaluate the interaction between a compound and its target site before synthesizing a compound so as to increase the ability by reducing the side effects.

Various software used :

  • Chem Sketch
  • Mol inspiration
  • Swiss ADME
  • Pro Tox 3.0

MOL INSPIRATION

This software is used to calculate the following properties

  • Log P
  • Molecular weight
  • Number of H-bond donor
  • Number of H-bond acceptor
  • Number of rotatable bonds

In addiction to “LIPINSKI’S RULE” another rule was proposed VEBER he states that the number of rotatable bonds should be less than 10. This rule is more appropriate for oral drug only. According to the veber’s  rule .

  1. The Log P value should not be more than 5
  2. The molecular weight of the compound should not more than 500
  3. No. of H-bond donor not more than 5
  4. No. of rotatable bonds should not be more than 10

3D STRUCTURAL VIEW OF COMPOUNDS:

 

 

SCOPOLETIN

 

 

LINALOOL

 

 

RUTIN

 

 

GALLIC ACID

 

 

CAFEIC ACID

 

 

URSOLIC ACID

 

 

OLEANOLIC ACID

 

 

β-SITOSTEROL

 

 

URSANE

 

 

TANNIC ACID

 

 

CATECHIN

 

 

EPICATECHIN

 

 

DEACETYL ASPERULOSIDIC ACID(DAA)

 

 

ASPERULOSIDIC ACID(AA)

 

 

TIGOGENIN

 

 

OLEONANE

 

 

QUERCETIN

 

 

KAEMPFEROL

Table-1: Properties of Phytoconstituents

Sr. No

Phytoconstituents

PubChem Id

Molecular Weight

Molecular Formula

1

Scopoletin

5280460

192.17 g/mol

C10H8O4

2

Quercetine

5280343

302.23 g/mol

C15H10O7

3

Kaempferol

5280863

286.24 g/mol

C15H10O6

4

Rutin

6728944

610.5 g/mol

C27H30O16

5

Gallic Acid

370

170.12g/mol

C7H6O5

6

Caffeic Acid

689043

180.16g/mol

C9H8O4

7

Ursolic Acid

64945

456.7g/mol

C30H48O3

8

Oleanolic Acid

10494

456.7g/mol

C30H48O3

9

Β-SITOSTEROL

222284

414.7g/mol

C29H50O

10

Linalool

6549

154.25g/mol

C10H18O

11

Tannic Acid

16129778

1701.2g/mol

C76H52O46

12

Catechin

9064

290.27g/mol

C15H14O6

13

Epicatechin

72276

290.27g/mol

C15H14O6

14

Deacetylasperulosidic Acid (DAA)

12315350

390.34g/mol

C16H22O11

15

Asperulosidic Acid (AA)

119688

432.4g/mol

C18H24O12

16

Tigogenin

99516

416.6 g/mol

C27H44O3

17

Oleanane

9548717

412.27 g/mol

C56H92O29

18

Ursane

9548870

412.7 g/mol

C30H52

Table-2: ADME Properties of Phytoconstituents

Sr. No.

Phytoconstituents

Number of Rotatabe  Bonds

Number of Bond Acceptor

Number of Bond Donor

Lpgpc/ W9 (Liogl)

Molar Refractive

Solubility

Gastro

Intestinal Absorption

1

Scopoletin

1

4

1

1.86

51.00

Soluble

High

2

Quercetine

1

7

5

1.63

78.03

Soluble

High

3

Kaempferol

1

6

4

1.70

76.01

Soluble

High

4

Rutin

6

16

10

0.46

141.38

Soluble

Low

5

Gallic Acid

1

5

4

0.21

39.47

Soluble

High

6

Caffeic Acid

2

4

3

0.97

47.16

Soluble

High

7

Ursolic Acid

1

3

2

3.95

136.91

Moderately

Soluble

Low

8

Oleanolic Acid

1

3

2

3.94

136.65

Paartially Soluble

Low

9

Β-Sitosterol

6

1

1

5.05

133.23

Partially

.Soluble

Low

10

Linalool

4

1

1

2.70

50.44

Soluble

High

11

Tannic Acid

10

19

11

0.36

142.56

Soluble

Low

12

Catechin

1

6

5

1.33

74.33

Soluble

High

13

Epicatechin

1

6

5

1.47

74.33

Soluble

High

14

Deacetyl

Asperulosidic Acid (DAA)

5

11

7

0.58

83.73

Soluble

Low

15

Asperulosidic

Acid (AA)

7

12

6

1.13

93.47

Soluble

Low

16

Tigogenin

7

13

1

4.53

122.07

Moderately

.Soluble

High

17

Oleanane

0

0

0

5.05

134.19

Partially

.Soluble

Low

18

Ursane

0

0

0

5.02

134.45

Partially

.Soluble

Low

Table 3: Toxicity Study of Phytoconstituents

Sr. No

 

Phyto-Constituents

Nephlo

Toxicity

Carcino-toxicity

Cardio

Toxicity

Muta Geneciy

Cyto

Toxicity

Bbb-Barrier

Nutritional Toxicity

 

 

Aryl- Hydro-Carbon Receptor

Andro

Gen

Receptr

1

Scopoletin

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

2

Quercetin

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

3

Kaempferol

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

4

Rutin

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

5

Gallic Acid

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

6

Caffeic Acid

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

7

Ursolic Acid

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

8

Oleanolic Acid

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

9

Β-Sitosterol

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

10

Linalool

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

11

Tannic Acid

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

12

Catechin

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

13

Epicatechin

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

14

Deacetyl-asperulosidic Acid (DAA)

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

15

Asperulo-Sidic Acid

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

16

Tigogenin

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

17

Oleanane

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

18

Ursane

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

Inactive

ANTI MICROBIAL ACTIVITY

PREPARATION OF PROTEIN:

The protein target, obtained from the RCSB protein data bank  with the PDB accession. Code 1ULK function as docking receptor. The active site of the receptor was cleared of all sound ligands and water molecules.

CRYSTAL STRUCTURE OF 1ULK

PDB DOI: https://doi.org/10.2210/pdb1ULK/pdb

Classification: SUGAR BINDING PROTEIN

Organism(s): Phytolacca americana

Mutation(s): No

Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.80 Å
  • R-Value Free: 0.203 (Depositor)
  • R-Value Work: 0.176 (Depositor)
  • R-Value Observed: 0.176 (Depositor)

BINDING AFFINITY

Sr. No

Phytoconstituents

Binding Affinity

1

Ciproflaxacin

-7.0023

2

Tannic Acid

-10.3872

3

Rutin

-8.1195

4

Beta Sitosterol

-7.4976

5

Asperulosidic Acid

-7.4150

6

Deacetyl Asperulosidic Acid (Daa)

-7.3563

7

Urasane

-7.0970

8

Ursolic Acid

-7.0485

9

Oleonane

-7.0445

10

Oleanolic Acid

-6.9786

11

Tigogenin

-6.7315

12

Epicatechin

-6.7252

13

Quercetin

-6.7019

14

Kaemoferol

-6.6495

15

Catechin

-6.6175

16

Scopoletin

-6.2459

17

Linalool

-6.2316

18

Caffeic Acid

-6.1923

19

Gallic Acid

-5.8714

MATRIALS AND METHOD

Processing of plant :

The collected plant has identified by Dr.V.Suresh kumar, Assistant Professor, Dept of Botany, Government Arts College, Tiruvannamalai (District), Tamilnadu, India. The plant was washed with tap water 3 times and sterilized by spraying with 70% alcohol.

The purified plant material was shade dried at room temperature to avoid chemical changes and frequently observed for any fungal contamination as the plant material rich in water content. When the plant material was dried entirely, it has subjected to prepare fine powder with help of mixer grinder. The fine material powder is collected and used for extraction of the crude drug in solvent by soxhlet and maceration extraction method.

DRIED FLOWERS

Soxhlet Extraction:

Soxhlet extraction is a method used to remove active compounds from plant material using heat and continuous solvent washing.

Maceration:

Maceration is a method of extracting compounds by soaking plant material in a solvent at room temperature for a long time.

Soxhlet Extraction

Apparatus:

  • Soxhlet extractor
  • Round bottom flask
  • Condenser
  • Heating mantle / water bath, Thimble (filter paper)
  • Solvent (ethanol, acetone, etc.)

Procedure:

  • Dry and powder the plant material.
  • Place the powdered sample inside a thimble.
  • Insert the thimble into the Soxhlet extractor.
  • Add solvent into the round bottom flask.
  • Attach condenser on top.
  • Heat the system.
  • Solvent evaporates → condenses → drips into thimble.
  • When chamber fills, siphon tube returns extract to flask.
  • This cycle repeats for 6–8 hours.
  • After extraction, evaporate solvent to obtain crude extract.

Advantages

  • Efficient extraction
  • Uses less solvent
  • Continuous extraction

Disadvantages

  • Time consuming
  • Not suitable for heat-sensitive compounds

Maceration

Apparatus:

  • Conical flask / beaker
  • Stopper or aluminum foil
  • Stirring rod
  • Filter paper
  • Funnel

Procedure

  • Dry and powder plant material.
  • Place powder in a flask.
  • Add suitable solvent (enough to cover sample).
  • Close the flask.
  • Keep for 24–72 hours at room temperature.                                   
  • Shake occasionally.
  • Filter the solution.                                                        
  • Evaporate solvent to get extract.

Advantages

  • Simple method
  • No heating required
  • Suitable for heat-sensitive compounds

Disadvantages

  • Takes longer time
  • Less efficient than Soxhlet
                  

 

                                Maceration process                                                     Soxhlet method

CONFIRMATION TESTS FOR CRUDE EXTRACTS

Sr. No

CHEMICAL CONSTITUENTS

TEST

INFERENCE

1.

ALKALOIDS

Dragendroff’s test

+ve

Mayer’s test

+ve

Wager’s test

+ve

Hager’s test

+ve

2.

FLAVANOIDS

Alkaline reagent test

+ve

Lead acetate test

+ve

3.

SAPONINS

Foam test

-ve

Emulsifiction test

+ve

4.

TANNINS

Ferric chloride test

+ve

Lead acetate test

+ve

5.

GLYCOSIDES

Keller-killianin test

(for cardiac glycosides)

-ve

Borntagger’s test

(for anthraquinone glycosides)

+ve

6.

PHENOLS

Ferric chloride test

+ve

Lead acetate test

+ve

METHOD

  • In-vitro Anti microbial activity of plant extract

Plant extracts possess significant antimicrobial activity due to compounds like alkaloids, flavonoids, tannins and essential oil, Phenols offering natural alternative to synthetic drugs by inhibiting various bacteria and fungi, targeting pathogens like (BACILLUS, STAPHYLOCOCCUS).

Preparation of nutrient broth medium:

Sr. No

Composition

Standard Formula (1000ml)

Working Formula (500ml)

1

Beef Extract

3 G

1.5 G

2

Peptone

5 G

2.5 G

3

Sodium Chloride

5 G

2.5 G

4

Agar

15 G

7.5 G

5

Distilled Water

1000ml

500ml

PROCEDURE:

  • Weigh above all ingredients and make up 500 ml with distilled water.
  • Mix well and constant stirring until the power dissolves completely.
  • Autoclave the medium at 121 ? C for 15 minutes under 15psi pressure.
  • Cool to about 45?C.
  • Pour into sterile petri dishes (20ml per plate).
  • Spread the microbial suspension evenly over the surface of the agar plate using a sterile swab to create a lawn of growth.
  • Incubate at 37 ?C for 48hours.

COMMON METHODS:

  1. Disc diffusion method (standard-ciprofloxacin, sample-crude drug).
  2. Agar well diffusion method (make small well in the agar & fill with the (standard & sample).
  • Measure inhibition zones around plant extract discs and well.
  • Larger zones indicate greater antimicrobial potency.

BACILLUS

     

 

                                    STANDARD                                                                SAMPLE

STAPHYLOCOCCUS

     

 

STANDARD                                                        SAMPLE

SERIAL DILUTION:

BLANK:

Add 1.5 g of Beef extract

Add 2.5 g of Peptone

Add 2.5 g of Sodium chloride

Make up for 500ml with distilled water

Autoclave the medium at 121?C for 15 minutes under psi pressure

Cool to about 45-50 ?C

Incubate at 37 ?C for 48 hours

Measure absorbance at 254nm

CONTROL:

Add 10ml of nutrient broth

Add 0.5ml of Micro-organism (Bacillus, Staphylococcus)

Incubate at 37 ? C for 48hours

Measure the absorbance at 254nm

STANDARD:

Add 10 ml of nutrient broth solution

Add 0.5 ml of micro-organism (bacillus, staphylococcus)

Add 0.5ml of 50 mcg Ciprofloxacin solution

Incubate at 37 ?C for 48 hours

Measure the absorbance at 254nm

TEST:

TEST FOR

100 mcg/ml, 200 mcg/ml, 300 mcg/ml, 400 mcg/ml, 500 mcg/ml, 600 mcg/ml, 700 mcg/ml, 800 mcg/ml, 900 mcg/ml, 1000 mcg/ml.

Add 10ml of nutrient broth solution

Add0.5ml of micro-organism (Bacillus & Staphylococcus)

Add 0.5ml of plant extract

Incubate at 37 ?C for 48 hours

Measure the absorbance at 254nm

RESULT

Sr.

No

Sample

Conc

(Mcg)

Absorbance

(Staphylo Coccus)

Absorbance

(Bacillus)

% Inhibition

(Staphylo Coccus)

% Inhibition

(Bacillus)

 

Control

 

2.1690

2.1690

0%

0%

 

Cipro-

Floxacin

50

0.4218

0.3042

80.55%

85.97%

1

Test

100

1.4314

1.3812

34.00%

36.32%

2

Test

200

0.8422

0.8599

61.17%

60.35%

3

Test

300

0.8333

0.8448

61.58%

61.05%

4

Test

400

0.7811

0.8183

63.98%

62.27%

5

Test

500

0.7009

0.5114

67.68%

76.42%

6

Test

600

0.6962

0.4227

67.90%

80.51%

7

Test

700

0.6849

0.3826

68.42%

82.36%

8

Test

800

0.4569

0.3809

78.93%

82.43%

9

Test

900

0.4363

0.3042

79.88%

85.97%

10

Test

1000

0.4212

0.1684

80.55%

92.23%

CALCULATION FORMULA:

% of inhibition =

(Absorbance of control - Absorbance of  test) ×100

                 (Absorbance of control)

OBSERVATION

  • Ciprofloxacin at 50µg/ml showed 80-85% inhibition, validation of an assay.
  • The plant extract showed dose-dependent inhibition, reaching 80-92% at 1000µg/ml
  • This suggests that the extract contains active phytochemicals capable of inhibiting cell wall synthesis, potentially beneficial for managing micro-organism.

GRAPH

DISCUSSION:

1. Phytochemical Analysis

Preliminary phytochemical screening confirmed the presence of:

  • Flavonoids
  • Alkaloids
  • Tannins
  • Phenolic compounds
  • Terpenoids
  • Saponins

These compounds are known for their antimicrobial activity.

2. Antimicrobial Activity (Disc and Agar Well Diffusion Methods)

The antimicrobial activity was tested against:

  • Staphylococcus aureus
  • Bacillus subtilis

Both disc diffusion and well diffusion methods showed measurable zones of inhibition. Larger zones were observed at higher concentrations of extract. Well diffusion method showed slightly higher inhibition compared to disc diffusion method. The extract exhibited stronger activity against Staphylococcus aureus than Bacillus subtilis.

3. Serial Dilution and Percentage Inhibition

Serial dilution method was used to determine Minimum Inhibitory Concentration (MIC).As concentration decreased, percentage inhibition also decreased. Highest concentration showed maximum microbial inhibition. MIC was determined as the lowest concentration showing no visible growth. Percentage inhibition was calculated using:

% of inhibition   =

 Absorbance of control - Absorbance of  testAbsorbance of control ×100

 

Results indicated concentration-dependent antimicrobial activity.

4. Molecular Docking Analysis

Major phytocompounds from Morinda citrifolia were docked against microbial target proteins. Strong binding affinity was observed. Hydrogen bonding and hydrophobic interactions stabilized ligand-protein complexes. Docking scores supported the experimental antimicrobial results. This confirms that phytochemicals may inhibit microbial growth by interacting with essential proteins involved in cell wall synthesis and metabolic pathways.

CONCLUSION:

The present study demonstrates that Morinda citrifolia (Flowers) possesses significant antimicrobial activity against bacteria.  The disc diffusion and well diffusion methods confirmed concentration-dependent inhibition, while serial dilution determined the MIC and percentage inhibition.

Phytochemical screening revealed the presence of bioactive compounds responsible for antimicrobial effects. Molecular docking analysis further supported these findings by showing strong interaction between plant phytoconstituents and microbial target proteins.

Therefore, Morinda citrifolia (Flowers) can be considered a promising natural antimicrobial agent and may be used in the development of alternative therapeutic drugs to combat microbial resistance.

REFERENCES

    1. Woods GL., In vitro testing of antimicrobial agents, Infectious Disease Clinics of North America, 1995; 9(3):463–481.
    2. Leekha S, Terrell CL, Edson RS, General principles of antimicrobial therapy, Mayo Clinic Proceedings, 2011;86(2):156–167.
    3. Suresh V, Senthilkumar SK, Jayaseelan K, Johnson Mary A, Punitha Sri R, In-silico and in-vitro evaluation of antidiabetic potential of Blepharis maderaspatensis ethanolic extract, World J Pharm Res, 2025;14(16).
    4. Houš? J, Spížek J, Havlí?ek V., Antifungal drugs. Metabolites, 2020;10(3):106.
    5. Arakawa, Tsutomu; Yamasaki, Hisashi; Ikeda, Keiko; Ejima, Daisuke; Naito, Takeshi; Koyama, A. Hajime, Antiviral and Virucidal Activities of Natural Products, Current Medicinal Chemistry,2009,16 (20): 2485–2497.
    6. Kappagoda S, Singh U, Blackburn BG, Antiparasitic therapy, Mayo Clinic Proceedings, 2011;86(6):561–583.
    7. Kusrini E, Hashim F, Azmi WN, Amin NM, Estuningtyas A. A novel antiamoebic agent against Acanthamoeba sp. – a causative agent for eye keratitis infection. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2016;153:714–721.
    8. Molina JM, Tourneur M, Sarfati C, et al. Fumagillin treatment of intestinal microsporidiosis. The New England Journal of Medicine. 2002;346(25):1963–1969.
    9. Antiparasitics. Purdue University Cytology Laboratories. Purdue Research Foundation, 2015.
    10. Zich FA, Hyland BPM, Whiffen T, Kerrigan RA. Morinda citrifolia. In: Australian Tropical Rainforest Plants. 8th ed. Centre for Australian National Biodiversity Research; 2020.
    11. Morinda citrifolia L. Flora of China (eFloras). St. Louis (MO) & Cambridge (MA): Missouri Botanical Garden; Harvard University Herbaria, 2024.
    12. Kokat CK. Pharmacognosy 16th Edn, NialiPrakasham, Mumbai India 2001.
    13. Senthilmurugan GB, Vasanthe B, Suresh K. Screening and antibacterial activity analysis of some important medicinal plants, International Journal of Innovation and Applied Studies 2013;2(2):146-152.
    14. Harborne JB. Phytochemical Method: Modern method Guidelines of plants analysis (Bandung: ITB) Indonesia, 1987.
    15. Wang MY, West BJ, Jensen CJ, Nowicki D, Chen SU, Palu AK Anderson G. Morinda citrifolia (Noni), A literature review and recent advances in Noni research. ActaPharmacol Sin. 23(12); 2002: 1127-114.
    16. Morinda citrifolia – Indian mulberry. Cook Islands Biodiversity. The Cook Islands Natural Heritage Trust, 2024.
    17. Wong KM, et al. Rubiaceae. In: Flora of Singapore. Singapore: Singapore Botanic Gardens; p. 182, 2024.
    18. T.P.T. Cushnie et al. Recent advances in understanding the antibacterial properties of flavonoids International Journal of Antimicrobial Agents, 2004.
    19. T.P.T. Cushnie et al. Antimicrobial activity of flavonoids, International Journal of Antimicrobial Agents, 2005.
    20. Nita T, Arai T, Takamatsu H, et al. Antibacterial activity of extracts prepared from tropical and subtropical plants on methicillin-resistant Staphylococcus aureus. Journal of Health Science. 2002;48:273–276.
    21. Atefl DA, Erdo?rul ÖT. Antimicrobial activities of various medicinal and commercial plant extracts. Turkish Journal of Biology. 2003;27:157–162.
    22. Abdulrahman et al., 2010 M.S. Abdulrahman, S. Thangaraj, S.M. Salique, K.F. Khan, S.E. Natheer, Antimicrobial and biochemical analysis of some spices extracts against food spoilage pathogens Int. J. Food Safety, 2010, pp. 71-75.
    23. Akinpelu et al., 2015 D.A. Akinpelu, O.A. Aiyegoro, O.F. Akinpelu, A.I. Okah, Stem bark extract and fraction of Persea americana (Mill) exhibits bactericidal activities against strains of Bacillus cereus associated with food poisoning Molecules, 2015,pp. 416-429.
    24. Marasini B. P., Baral P., Aryal P. et al., Evaluation of antibacterial activity of some traditionally used medicinal plants against human pathogenic bacteria, BioMed Research International. 2015, 6, 265425.
    25. Romero C. D., Chopin S. F., Buck G., Martinez E., Garcia M., and Bixby L., Antibacterial properties of common herbal remedies of the southwest, Journal of Ethnopharmacology. 2005, 99, no. 2, 253–257.
    26. Awadh Ali NA, Julich WD, Kusnick C, Lindequist U. Screening of Yemeni medicinal plants for antibacterial and cytotoxic activities. Journal of Ethnopharmacology. 2001;74:173–179.
    27. Garcia VMN, Gonzalez A, Fuentes M, Aviles R, Rios MY, Zepeda G, Rojas MG. Antifungal activities of nine traditional Mexican medicinal plants. Journal of Ethnopharmacology. 2003;87:85–88.
    28. Dülger B, Y?lmaz F, Gücin B. Antimicrobial activity of the macrofungi Macrolepiota procera (Scop. ex Fr.) Sing. Kükem Dergisi. 1998;21(1):7–12.
    29. S.S. Chang et al, Natural antioxidants from rosemary and sage, Journal of Food Science, 1977.
    30. H. Kikuzaki et al, Antioxidant Effects of Some Ginger Constituents, Journal of Food Science, 1993.
    31. Lourdu Jafrin A, Shanti M, Meher Ali R. Anxiolytic effect of ondansetron, a 5-HT3 antagonist on male albino mice in the elevated plus maze. Res J Pharm Biol Chem Sci. 2013;4:1665–75.
    32. Vaseghi G, Andalib S, Rabbani M, Sajjadi SE, Jafarian A. Hypnotic Effect of Salvia reuterana Boiss for Treatment of Insomnia. J Med Plants. 2013; 12:7–13.
    33. DeFronzo RA, Ferrannini E, Groop L, Henry RR, Herman WH, Holst JJ, Hu FB, Kahn CR, Raz I, Shulman GI, Simonson DC, Testa MA, Weiss R. Type 2 diabetes mellitus. Nature Reviews Disease Primers. 2015; 1:15019.
    34. Cilla A, Alegría A, De Ancos B, Sánchez-Moreno C, Cano MP, Plaza L, Clemente G, Lagarda MJ, Barbera R. Bioaccessibility of tocopherols, carotenoids, and ascorbic acid from milk- and soy-based fruit beverages: influence of food matrix and processing. Journal of Agricultural and Food Chemistry. 2012;60(29):7282–7290.
    35. Hirazumi AY. Antitumor studies of a traditional Hawaiian medical plant, Morinda citrifolia (Noni), in vitro and in vivo [dissertation]. Honolulu (HI): University of Hawaii; 1997.
    36. Hirazumi, A., E. Furusawa, S.C. Chow & Y. Hokama. 1994. Anticancer activity of Morinda citrifolia (noni) in intraperitoneally implanted Lewis lung carcinoma in syngeneic mice. Proc. West. Pharmacol. Soc. 37: 145–146.
    37. Farine JP, Legal L, Moreteau B, Le Quere JL. Volatile components of ripe fruits of Morinda citrifolia and their effects on Drosophila. Phytochem. 41; 1996: 433.
    38. E. Lopez-Oviedo, A.I. Aller, C. Martín, et al. Evaluation of disk diffusion method for determining posaconazole susceptibility of filamentous fungi?: comparison with CLSI broth microdilution method Antimicrob. Agents Chemother., 50 (2006), pp. 1108-1111.
    39. S. Magaldi, S. Mata-Essayag, C. Hartung de Capriles, et al. Well diffusion for antifungal susceptibility testing Int. J. Infect. Dis., 8 (2004), pp. 39-45.
    40. Mounyr Balouiri, Moulay Sadiki, Saad Koraichi Ibnsouda, Methods for in vitro evaluating antimicrobial activity: A review, Journal of Pharmaceutical Analysis, Volume 6, Issue 2, April 2016, Pages 71-79.

Reference

  1. Woods GL., In vitro testing of antimicrobial agents, Infectious Disease Clinics of North America, 1995; 9(3):463–481.
  2. Leekha S, Terrell CL, Edson RS, General principles of antimicrobial therapy, Mayo Clinic Proceedings, 2011;86(2):156–167.
  3. Suresh V, Senthilkumar SK, Jayaseelan K, Johnson Mary A, Punitha Sri R, In-silico and in-vitro evaluation of antidiabetic potential of Blepharis maderaspatensis ethanolic extract, World J Pharm Res, 2025;14(16).
  4. Houš? J, Spížek J, Havlí?ek V., Antifungal drugs. Metabolites, 2020;10(3):106.
  5. Arakawa, Tsutomu; Yamasaki, Hisashi; Ikeda, Keiko; Ejima, Daisuke; Naito, Takeshi; Koyama, A. Hajime, Antiviral and Virucidal Activities of Natural Products, Current Medicinal Chemistry,2009,16 (20): 2485–2497.
  6. Kappagoda S, Singh U, Blackburn BG, Antiparasitic therapy, Mayo Clinic Proceedings, 2011;86(6):561–583.
  7. Kusrini E, Hashim F, Azmi WN, Amin NM, Estuningtyas A. A novel antiamoebic agent against Acanthamoeba sp. – a causative agent for eye keratitis infection. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2016;153:714–721.
  8. Molina JM, Tourneur M, Sarfati C, et al. Fumagillin treatment of intestinal microsporidiosis. The New England Journal of Medicine. 2002;346(25):1963–1969.
  9. Antiparasitics. Purdue University Cytology Laboratories. Purdue Research Foundation, 2015.
  10. Zich FA, Hyland BPM, Whiffen T, Kerrigan RA. Morinda citrifolia. In: Australian Tropical Rainforest Plants. 8th ed. Centre for Australian National Biodiversity Research; 2020.
  11. Morinda citrifolia L. Flora of China (eFloras). St. Louis (MO) & Cambridge (MA): Missouri Botanical Garden; Harvard University Herbaria, 2024.
  12. Kokat CK. Pharmacognosy 16th Edn, NialiPrakasham, Mumbai India 2001.
  13. Senthilmurugan GB, Vasanthe B, Suresh K. Screening and antibacterial activity analysis of some important medicinal plants, International Journal of Innovation and Applied Studies 2013;2(2):146-152.
  14. Harborne JB. Phytochemical Method: Modern method Guidelines of plants analysis (Bandung: ITB) Indonesia, 1987.
  15. Wang MY, West BJ, Jensen CJ, Nowicki D, Chen SU, Palu AK Anderson G. Morinda citrifolia (Noni), A literature review and recent advances in Noni research. ActaPharmacol Sin. 23(12); 2002: 1127-114.
  16. Morinda citrifolia – Indian mulberry. Cook Islands Biodiversity. The Cook Islands Natural Heritage Trust, 2024.
  17. Wong KM, et al. Rubiaceae. In: Flora of Singapore. Singapore: Singapore Botanic Gardens; p. 182, 2024.
  18. T.P.T. Cushnie et al. Recent advances in understanding the antibacterial properties of flavonoids International Journal of Antimicrobial Agents, 2004.
  19. T.P.T. Cushnie et al. Antimicrobial activity of flavonoids, International Journal of Antimicrobial Agents, 2005.
  20. Nita T, Arai T, Takamatsu H, et al. Antibacterial activity of extracts prepared from tropical and subtropical plants on methicillin-resistant Staphylococcus aureus. Journal of Health Science. 2002;48:273–276.
  21. Atefl DA, Erdo?rul ÖT. Antimicrobial activities of various medicinal and commercial plant extracts. Turkish Journal of Biology. 2003;27:157–162.
  22. Abdulrahman et al., 2010 M.S. Abdulrahman, S. Thangaraj, S.M. Salique, K.F. Khan, S.E. Natheer, Antimicrobial and biochemical analysis of some spices extracts against food spoilage pathogens Int. J. Food Safety, 2010, pp. 71-75.
  23. Akinpelu et al., 2015 D.A. Akinpelu, O.A. Aiyegoro, O.F. Akinpelu, A.I. Okah, Stem bark extract and fraction of Persea americana (Mill) exhibits bactericidal activities against strains of Bacillus cereus associated with food poisoning Molecules, 2015,pp. 416-429.
  24. Marasini B. P., Baral P., Aryal P. et al., Evaluation of antibacterial activity of some traditionally used medicinal plants against human pathogenic bacteria, BioMed Research International. 2015, 6, 265425.
  25. Romero C. D., Chopin S. F., Buck G., Martinez E., Garcia M., and Bixby L., Antibacterial properties of common herbal remedies of the southwest, Journal of Ethnopharmacology. 2005, 99, no. 2, 253–257.
  26. Awadh Ali NA, Julich WD, Kusnick C, Lindequist U. Screening of Yemeni medicinal plants for antibacterial and cytotoxic activities. Journal of Ethnopharmacology. 2001;74:173–179.
  27. Garcia VMN, Gonzalez A, Fuentes M, Aviles R, Rios MY, Zepeda G, Rojas MG. Antifungal activities of nine traditional Mexican medicinal plants. Journal of Ethnopharmacology. 2003;87:85–88.
  28. Dülger B, Y?lmaz F, Gücin B. Antimicrobial activity of the macrofungi Macrolepiota procera (Scop. ex Fr.) Sing. Kükem Dergisi. 1998;21(1):7–12.
  29. S.S. Chang et al, Natural antioxidants from rosemary and sage, Journal of Food Science, 1977.
  30. H. Kikuzaki et al, Antioxidant Effects of Some Ginger Constituents, Journal of Food Science, 1993.
  31. Lourdu Jafrin A, Shanti M, Meher Ali R. Anxiolytic effect of ondansetron, a 5-HT3 antagonist on male albino mice in the elevated plus maze. Res J Pharm Biol Chem Sci. 2013;4:1665–75.
  32. Vaseghi G, Andalib S, Rabbani M, Sajjadi SE, Jafarian A. Hypnotic Effect of Salvia reuterana Boiss for Treatment of Insomnia. J Med Plants. 2013; 12:7–13.
  33. DeFronzo RA, Ferrannini E, Groop L, Henry RR, Herman WH, Holst JJ, Hu FB, Kahn CR, Raz I, Shulman GI, Simonson DC, Testa MA, Weiss R. Type 2 diabetes mellitus. Nature Reviews Disease Primers. 2015; 1:15019.
  34. Cilla A, Alegría A, De Ancos B, Sánchez-Moreno C, Cano MP, Plaza L, Clemente G, Lagarda MJ, Barbera R. Bioaccessibility of tocopherols, carotenoids, and ascorbic acid from milk- and soy-based fruit beverages: influence of food matrix and processing. Journal of Agricultural and Food Chemistry. 2012;60(29):7282–7290.
  35. Hirazumi AY. Antitumor studies of a traditional Hawaiian medical plant, Morinda citrifolia (Noni), in vitro and in vivo [dissertation]. Honolulu (HI): University of Hawaii; 1997.
  36. Hirazumi, A., E. Furusawa, S.C. Chow & Y. Hokama. 1994. Anticancer activity of Morinda citrifolia (noni) in intraperitoneally implanted Lewis lung carcinoma in syngeneic mice. Proc. West. Pharmacol. Soc. 37: 145–146.
  37. Farine JP, Legal L, Moreteau B, Le Quere JL. Volatile components of ripe fruits of Morinda citrifolia and their effects on Drosophila. Phytochem. 41; 1996: 433.
  38. E. Lopez-Oviedo, A.I. Aller, C. Martín, et al. Evaluation of disk diffusion method for determining posaconazole susceptibility of filamentous fungi?: comparison with CLSI broth microdilution method Antimicrob. Agents Chemother., 50 (2006), pp. 1108-1111.
  39. S. Magaldi, S. Mata-Essayag, C. Hartung de Capriles, et al. Well diffusion for antifungal susceptibility testing Int. J. Infect. Dis., 8 (2004), pp. 39-45.
  40. Mounyr Balouiri, Moulay Sadiki, Saad Koraichi Ibnsouda, Methods for in vitro evaluating antimicrobial activity: A review, Journal of Pharmaceutical Analysis, Volume 6, Issue 2, April 2016, Pages 71-79.

Photo
Dr. Suresh V
Corresponding author

Arunai College of Pharmacy, Tiruvannamalai, Tamil Nadu, India

Photo
Dr. Senthilkumar S. K
Co-author

Arunai College of Pharmacy, Tiruvannamalai, Tamil Nadu, India

Photo
Jayaseelan K
Co-author

Arunai College of Pharmacy, Tiruvannamalai, Tamil Nadu, India

Photo
Arunadevi L
Co-author

Arunai College of Pharmacy, Tiruvannamalai, Tamil Nadu, India

Photo
Blessy Bavina V
Co-author

Arunai College of Pharmacy, Tiruvannamalai, Tamil Nadu, India

Photo
Chandramouli S
Co-author

Arunai College of Pharmacy, Tiruvannamalai, Tamil Nadu, India

Photo
Charumathi. E
Co-author

Arunai College of Pharmacy, Tiruvannamalai, Tamil Nadu, India

Photo
Deepa. R
Co-author

Arunai College of Pharmacy, Tiruvannamalai, Tamil Nadu, India

Dr. Suresh V, Dr. Senthilkumar S. K, Jayaseelan K, Arunadevi L, Blessy Bavina V, Chandramouli S, Charumathi. E, Deepa. R, Integrated In Silico and In Vitro Investigation of Antimicrobial Activity of Morinda citrifolia Ethanolic Extract, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 2, 4124-4141. https://doi.org/10.5281/zenodo.18776487

More related articles
Excipient-Induced Hypersensitivity: A Case Study a...
Kanish Akash Rajkumar, Kothapalli Nagapavani, Manish Kumar S, ...
In silico anti-diabetic (?-glucosidase) inhibitory...
Dr. Anoob Kumar K I, Reshma Kurup, Reshadh T A, Archana M, Dr. La...
A Systematic Review of The Association Between Adulthood and Psychological Stres...
Jennila Meghana, Bhadrachalam Rohini, Sanjana Sahu, Paila Bhanujirao, ...
Formulation And Evaluation Of Floating Sustain Release Tablet Of Ranolazine ...
Samrudh kiran Shinde, Shivaji Patil, Namrata Satkar, Pritam Salokhe, Nilesh Chougule, ...
Formulation And Evaluation Of Chamomile And Jojoba Oil Infused Face Cream...
Dhuryav M. Nimkar , Yogita R. Choudhari , Neha K. Ghule, ...
Related Articles
Next-Generation Topical Delivery: The Rise of In Situ Gelling Systems...
Swati Joshi, Vishakha Devi, Jyoti Gupta, Maneesh Banyal, Nisha Devi, ...
The Role Of Stereochemistry And Formulation In Pharmacology Of The Drug...
Mohd Sharique Katchhi, Abrar Ahmed, Disha Kumareshi, Harshitha M. V., Chakure Aditya, ...
Formulation & Evaluation Of Herbal Sunscreen In Combination With Olive Oil Usefu...
Rutuja Golecha , Dr Vaishali Kate , Dr. Santosh Payghan , ...
Development and characterization of Phytosome as a novel carrier by QbD approach...
Ritika M. Revankar, Abhishek V. Desai, Nilesh B. Chougule, ...
More related articles
Excipient-Induced Hypersensitivity: A Case Study and Review ...
Kanish Akash Rajkumar, Kothapalli Nagapavani, Manish Kumar S, ...
In silico anti-diabetic (?-glucosidase) inhibitory activity of schiff’s base d...
Dr. Anoob Kumar K I, Reshma Kurup, Reshadh T A, Archana M, Dr. Lal Prasanth M L, ...
Excipient-Induced Hypersensitivity: A Case Study and Review ...
Kanish Akash Rajkumar, Kothapalli Nagapavani, Manish Kumar S, ...
In silico anti-diabetic (?-glucosidase) inhibitory activity of schiff’s base d...
Dr. Anoob Kumar K I, Reshma Kurup, Reshadh T A, Archana M, Dr. Lal Prasanth M L, ...